Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection.
about
Cryptococcus-Related Immune Reconstitution Inflammatory Syndrome (IRIS): Pathogenesis and its Clinical ImplicationsAdaptive immunity to fungiT cell-mediated host immune defenses in the lungCharacterization of IL-22 and antimicrobial peptide production in mice protected against pulmonary Cryptococcus neoformans infection.Role of IL-17A on resolution of pulmonary C. neoformans infectionFatal disseminated Cryptococcus gattii infection in New MexicoSTAT1 signaling is essential for protection against Cryptococcus neoformans infection in mice.Tc17 cells mediate vaccine immunity against lethal fungal pneumonia in immune deficient hosts lacking CD4+ T cells.Depletion of neutrophils in a protective model of pulmonary cryptococcosis results in increased IL-17A production by γδ T cells.Dectin-2 deficiency promotes Th2 response and mucin production in the lungs after pulmonary infection with Cryptococcus neoformans.Dendritic cell-based immunization ameliorates pulmonary infection with highly virulent Cryptococcus gattiiParadoxical Immune Responses in Non-HIV Cryptococcal MeningitisIs Development of a Vaccine against Cryptococcus neoformans Feasible?Prostaglandin E2 suppresses antifungal immunity by inhibiting interferon regulatory factor 4 function and interleukin-17 expression in T cells.IL-23 dampens the allergic response to Cryptococcus neoformans through IL-17-independent and -dependent mechanisms.An agonist of human complement fragment C5a enhances vaccine immunity against Coccidioides infection.Development of protective inflammation and cell-mediated immunity against Cryptococcus neoformans after exposure to hyphal mutants.Vaccine and immunotherapeutic approaches for the prevention of cryptococcosis: lessons learned from animal models.STAT1 signaling within macrophages is required for antifungal activity against Cryptococcus neoformansProtective immunity against pulmonary cryptococcosis is associated with STAT1-mediated classical macrophage activation.Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts.Antifungal Activity of Plasmacytoid Dendritic Cells against Cryptococcus neoformans In Vitro Requires Expression of Dectin-3 (CLEC4D) and Reactive Oxygen Species.The intracellular life of Cryptococcus neoformans.Identification and characterization of Cryptococcus neoformans protein fractions that induce protective immune responsesDefect of CARD9 leads to impaired accumulation of gamma interferon-producing memory phenotype T cells in lungs and increased susceptibility to pulmonary infection with Cryptococcus neoformans.Induction of protective immunity against cryptococcosis.Cryptococcus antigens and immune responses: implications for a vaccine.Innate host defenses against Cryptococcus neoformans.Extracellular vesicles from Paracoccidioides brasiliensis induced M1 polarization in vitro.Contribution of IL-1RI Signaling to Protection against Cryptococcus neoformans 52D in a Mouse Model of Infection.Vaccination with an alkaline extract of Histoplasma capsulatum packaged in glucan particles confers protective immunity in mice.Innate Immunity against Cryptococcus, from Recognition to Elimination.
P2860
Q24629367-1AFF057B-D606-4654-8882-51E871C973BDQ27025806-6A5355BB-8161-4019-AC0B-3899046E213FQ28395374-E5E63E3E-25C6-48F6-8CE2-C08FD9D0FDBEQ33827914-D44D8839-7D92-4A63-806A-06B56CC9C242Q33832023-9C4EA579-6D1A-4249-891E-86AD12CFD399Q34110199-2AC44B86-C178-4204-911B-3F3088DFD3C6Q34289451-22AC2D68-C37F-4EB2-BDA0-D192C2AFCF4EQ34350869-13A0A9F2-9EBE-4894-9558-BA0861AB4F45Q34502561-55ABE27C-7BA3-4DC9-97D1-DDEE01384A34Q34955594-48B47761-5C04-4911-9545-80E79D29E803Q35187555-4991D92D-26BB-44CC-863F-C9310D415DBAQ35645083-0DF12054-C4D2-4BBD-AC40-259966207A39Q35667534-F59075C0-ECF1-4B75-934C-67FDE71CC5B0Q35907174-58587546-FBEE-46B1-88F8-6FFF37E7761FQ35952109-D43E5DD4-71DF-46EC-BB11-5B799DE78A91Q36024806-2B9EB445-83C5-4A43-AC2A-468972D88545Q36177560-A9AB4839-92F3-497F-A320-90D73E0691C4Q36192774-ADEA94C8-3DFB-444A-8976-72C762B61996Q36281328-01FDAE21-512E-412B-8C1E-2CDFB10CF45BQ36303538-5767FE7F-E431-4079-A765-5BDF2C8C5D9DQ36431583-BDC61AB3-29D0-470D-AD25-AAB9A13B5E1AQ37199814-6D2A67BD-9F9A-44C4-B4A9-283174C209EAQ37452401-9896926A-DD44-4CA4-A127-ABF10C947883Q37562226-CF271746-6F6D-45FC-AECD-32606CBB8A49Q37713280-788C015D-AE74-4996-91D1-F184D36F92FFQ37965038-E46EEC36-3195-4AF8-81A2-6A00476DDAB0Q38155197-560A5741-CDC4-4642-B5C7-4A5E64C594EEQ38752388-05216F48-4142-4451-B724-CFA5012F3225Q40489103-DDE70DB8-97FA-4298-B48E-E94B6A4AAD17Q49447299-A2EDCEB9-8885-4C72-B0BE-33B6AD445089Q54220336-5BC34D78-7613-43F2-8318-45EAF29F8E46Q55421879-7868947F-B393-47BF-A802-5ABFCD42DFE8
P2860
Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection.
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Interleukin-17 is not required ...... tococcus neoformans infection.
@ast
Interleukin-17 is not required ...... tococcus neoformans infection.
@en
Interleukin-17 is not required ...... tococcus neoformans infection.
@nl
type
label
Interleukin-17 is not required ...... tococcus neoformans infection.
@ast
Interleukin-17 is not required ...... tococcus neoformans infection.
@en
Interleukin-17 is not required ...... tococcus neoformans infection.
@nl
prefLabel
Interleukin-17 is not required ...... tococcus neoformans infection.
@ast
Interleukin-17 is not required ...... tococcus neoformans infection.
@en
Interleukin-17 is not required ...... tococcus neoformans infection.
@nl
P2093
P2860
P356
P1476
Interleukin-17 is not required ...... ptococcus neoformans infection
@en
P2093
Floyd L Wormley
Jay K Kolls
Sarah E Hardison
P2860
P304
P356
10.1128/IAI.00845-10
P407
P577
2010-10-04T00:00:00Z